Mineralys Therapeutics | 4:持股變動聲明-高管 Rodman David Malcom
04/15 16:29 (美東)
Mineralys Therapeutics | EFFECT:其他
04/12 06:07 (美東)
Mineralys Therapeutics | 424B5:募資說明書
04/11 16:42 (美東)
Mineralys Therapeutics | ARS:年度報告
04/09 07:24 (美東)
Mineralys Therapeutics | DEFA14A:其他
04/09 07:20 (美東)
Mineralys Therapeutics | DEF 14A:股東委託書決議
04/09 07:19 (美東)
Mineralys Therapeutics | 8-K:重大事件
04/04 08:05 (美東)
Mineralys Therapeutics | S-3/A:特定交易註冊聲明(修正)
03/29 16:48 (美東)
Mineralys Therapeutics | 8-K:Mineralys Therapeutics公佈2023年第四季度和全年財務業績並提供公司最新情況
03/21 07:46 (美東)
Mineralys Therapeutics | S-3:特定交易註冊聲明
03/21 07:36 (美東)
Mineralys Therapeutics | 10-K:年度報表
03/21 07:21 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Rodman David Malcom
03/13 17:40 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Rodman David Malcom
02/15 16:28 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Levy Adam Scott
02/15 16:28 (美東)
Mineralys Therapeutics | 4:持股變動聲明-高管 Congleton Jon
02/15 16:28 (美東)
Mineralys Therapeutics | SC 13G:超過5%持股股東披露文件-TCG Crossover GP II, LLC(6.4%),TCG Crossover Fund II, L.P.(6.4%)等
02/15 16:23 (美東)
Mineralys Therapeutics | 4:持股變動聲明-董事 AKKARAJU SRINIVAS
02/14 21:08 (美東)
Mineralys Therapeutics | 4:持股變動聲明-股東 Samsara BioCapital GP, LLC
02/14 21:08 (美東)
Mineralys Therapeutics | 4:持股變動聲明-董事 RA CAPITAL MANAGEMENT, L.P.
02/14 19:53 (美東)
Mineralys Therapeutics | SC 13G:超過5%持股股東披露文件-Adams Street Partners, LLC(5.60%),Adams Street Growth Equity Fund VII LP(2.17%)等
02/14 06:07 (美東)
暫無數據
暫無數據